After two years of study, a federal drug advisory board has issued a recommendation that hair specimens be approved as an alternative for federal workplace drug-testing programs.
Powered by Suchmaschinenoptimierung
Transport Topics
- OPEC Cuts Output to Lowest Since 1991 as Virus Slams Oil Demand
- Safety Groups, Teamsters Petition FMCSA to Reconsider HOS Final Rule
- FedEx Posts Loss in Q4, Shows Improvement From Year Ago
- ASCE Report: COVID-19 Compounds Infrastructure Woes
- House Clears Extension of Small Business Loan Program to August
- Louisiana Passes Legislation Aimed at Significant Tort Reform
- Tesla Beats Delivery Expectations, Sending Shares Surging
- House Infrastructure Bill Will Never Become Law, Rep. Sam Graves Says
- FAA Concludes Three Days of Test Flights of Boeing’s 737 Max
- US Unemployment Falls to 11.1%; Trucking Adds 8,000 Jobs
- House OKs $1.5 Trillion Infrastructure Plan That Impacts HOS, Insurance
- Is Density Related to COVID-19 Infection Rates? These Experts Say No
- Cargo Theft Likely to Increase Over July Fourth Holiday, Report Says
- Daimler CEO Warns of ‘Drastic’ Pay Cuts, Deeper Restructuring
- Manufacturing Bounces Back in June on Reopenings
- CARB Releases Proposal to Cut Future NOx, Particulate Matter Emissions
- House Climate Change Plan Tackles Heavy-Duty Equipment at Ports
- Commodity Freighters Are Shrugging Off COVID-19 — For Now
- CBO Trims GDP Forecast for 2020, Lifts 2021 Projection
